Morning Market Movers

Inuvo

climbed 35.04% to $1.80 at 9:45 am. Inuvo's trailing-twelve-month revenue is $43.73 million. EntreMed

surged 17.27% to $1.63. EntreMed announced the publication of favorable results of a preclinical study in breast cancer of its oral Aurora A/angiogenic kinase inhibitor, ENMD-2076. Strategic Diagnostics

shares advanced 16.68% to $1.19. Strategic Diagnostics shares have dropped 42.70% over the past 52 weeks, while the S&P 500 index has gained 18.16% in the same period. Zhongpin

surged 15.84% to $12.58. Zhongpin entered into a definitive agreement and plan of merger with Golden Bridge Holdings Limited, Golden Bridge Merger Sub Limited, and Mr. Xianfu Zhu, the Company's Chairman and CEO.